S
SynaptiCure
Health Tech & Medtech · Chicago, United States · Founded 2019
Comprehensive ALS care platform integrating specialized neurology and local care coordination for optimized patient outcomes MoreLess
Synapticure.com is a telehealth startup that provides virtual care for individuals and caregivers dealing with neurodegenerative diseases such as ALS, Alzheimer’s, Huntington's, and Parkinson’s. The company operates in the healthcare market, specifically in the telehealth and neurology sectors.
The business model is centered around providing 24/7 access to neurologists, behavioral health providers, and care coordinators via telehealth. This means patients and caregivers can book appointments and receive care from the comfort of their own homes, without the need to travel to a physical location. This is particularly beneficial for those with mobility issues or who live in remote areas.
Synapticure also offers integrated behavioral health services, recognizing the emotional and psychological challenges that come with neurodegenerative diseases. The company prides itself on being informed by the latest science, helping patients understand their options and access new treatments or enroll in clinical trials.
The company generates revenue through the fees charged for the telehealth services provided. These fees are likely paid by the patients themselves, their insurance companies, or a combination of both.
The co-founders, Brian Wallach and Sandra Abrevaya, have personal experience with ALS, which adds a layer of empathy and understanding to the services provided. The company has received positive reviews for its knowledgeable and empathetic doctors, who are described as being on the cutting edge of neurodegenerative disease treatment.
Keywords: Telehealth, Neurology, ALS, Alzheimer’s, Huntington's, Parkinson’s, Behavioral Health, Virtual Care, Neurodegenerative Diseases, Caregivers.
Company overview
SynaptiCure company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Chicago, United States
- Employees
- 106
- Open positions
- 6
- Dealroom signal
- 85.8
Valuation & funding
SynaptiCure funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2024 | $25M | $100M | RA Capital Management · Rock Health Capital · CVS Health Ventures · GV | ↗ |
| SEEDEquity / VC | Nov 2022 | $0 | — | Rebel Fund | — |
| SEED✓Equity / VC | Feb 2022 | $6M | $24M | Martin Ventures · Lifeforce Capital · Byers Capital · GV | ↗ |
| SEED✓Equity / VC | Dec 2020 | $125K | $500K | Y Combinator | — |
| OtherOther financing | Aug 2020 | $0 | — | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 103 |
| 2025 | 93 |
| 2024 | 67 |
| 2023 | 51 |
| 2022 | 39 |
Growth signals
SynaptiCure website traffic
Latest recorded traffic for SynaptiCure is 19K monthly website visits, down 38.7% over the last three months. SynaptiCure's team grew 14% over the past year.
Hiring
Open positions at SynaptiCure
Current openings linked to this company in Dealroom.
Comparisons
SynaptiCure compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
SynaptiCure's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where SynaptiCure has talent and traffic
team presence
In the news
Latest news about SynaptiCure
Recent press, funding announcements, and product moves mentioning SynaptiCure — open to read from the original sources.
Market sentiment
What the market is saying about SynaptiCure
An AI-synthesized read of the highest-engagement posts about SynaptiCure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SynaptiCure’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.




























